Erratum: Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma

Franck Morschhauser

Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France

Gilles Salles

41Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Laurie H. Sehn

8Division of Medical Oncology, BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, Canada

Alex F. Herrera

10Duarte Cancer Center, City of Hope Medical Center, Duarte, CA

Jonathan W. Friedberg

18Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY

Marek Trneny

Georg Lenz

Jeff P. Sharman

1Willamette Valley Cancer Institute, Sarah Cannon Research, Eugene, OR

Charles Herbaux

John M. Burke

4Rocky Mountain Cancer Centers, US Oncology Research, Aurora, CO

Matthew Matasar

6Rutgers Cancer Institute, New Brunswick, United States

Graham P. Collins

32Department of Clinical Haematology, Oxford University Hospital, Oxford, United Kingdom

Neha Mehta-Shah

3Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO

Lucie Oberic

7Oncopole, Hematology, Toulouse, France

Adrien Chauchet

20CHU de Besançon – Hôpital Jean Minjoz, Besancon, France

Wojciech Jurczak

Yuqin Song

Antonio Pinto

15Department of Hematology, Istituto Nazionale Tumori Istituto di Ricovero e Cura a Carattere Scientifico “Fondazione G Pascale”, Naples, Italy

Shinya Rai

2British Columbia Cancer, Centre for Lymphoid Cancer, Vancouver, Canada

Koji Izutsu

National Cancer Center Hospital, Tokyo, Japan

Richard Greil

Larysa Mykhalska

Juan M. Bergua-Burgués

Matthew C. Cheung

Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Ho-jin Shin

Pusan National University Hospital, Busan, Korea, Republic of

Greg Hapgood

10Princess Alexandra Hospital, Department of Haematology, Brisbane, Australia

Eduardo Munhoz

1Hospital Erasto Gaertner / Instituto de Oncologia do Paraná, Hematoncology / BMT, Curitiba, Brazil

Pau Abrisqueta

Jyh-Pyng Gau

Yanwen Jiang

12Genentech, Inc, South San Francisco, CA

Bruce McCall

Genentech, Inc, South San Francisco, CA

Saibah Chohan

Matthew Sugidono

14Genentech, Inc., South San Francisco, CA

Mark Yan

15Hoffmann-La Roche Ltd, Mississauga, ON, Canada

Connie Lee Batlevi

12Genentech, Inc, South San Francisco, CA

Hervé Tilly

5Service Hématologie, Centre Henri Becquerel, Rouen, France

Christopher R. Flowers

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine